Analyst Ranking
Top 26%
#1372 out of 5290 analysts
Average Return
+4.04%
Win Rate
45%33 out of 73
Risk vs Reward
Poor
Good

Mason Carrico's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Caredx IncCDNA
+228.02%$7.21$23.65
2023-11-08 -
2024-11-08
Strong Buy
Natera IncNTRA
+154.88%$66.00$168.22
2024-01-29 -
2025-01-29
Strong Buy
Natera IncNTRA
+149.63%$67.50$168.50
2024-01-16 -
2025-01-16
Strong Buy
10x Genomics IncTXG
+133.91%$9.20$21.52
2025-05-14 -
2026-05-14
Strong Buy
Caredx IncCDNA
+120.05%$8.28$18.22
2024-04-16 -
2025-04-16
Strong Buy

Mason Carrico Analyst Color

Get additional color on Mason Carrico's coverage of popular stocks

Mason Carrico's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cytek Biosciences IncCTKB
3Strong Buy$4.75+9.70%Maintains
23 days ago
Natera IncNTRA
6Strong Buy$235.00+5.81%Maintains
7 months ago
Pacific Biosciences Of California IncPACB
5Strong Buy$2.00+22.70%Maintains
7 months ago
Hologic IncHOLX
6Hold$76.00-0.01%Downgrades
7 months ago
Neogenomics IncNEO
2Strong Buy$11.00-2.74%Maintains
9 months ago
Vericel CorpVCEL
3Strong Buy$67.00+87.73%Reiterates
a year ago
Illumina IncILMN
8Strong Buy$105.00N/AReiterates
a year ago
10x Genomics IncTXG
6Strong Buy$14.00N/AReiterates
a year ago
Caredx IncCDNA
10Strong Buy$40.00N/AReiterates
a year ago
Glaukos CorpGKOS
1Strong Buy$115.00N/AMaintains
a year ago
Veracyte IncVCYT
4Strong Buy$45.00N/AReiterates
a year ago
Insight Molecular Diagnostics IncIMDX
4Hold$4.00N/AReiterates
a year ago
Guardant Health IncGH
5Strong Buy$55.00N/AReiterates
a year ago
Akoya Biosciences IncAKYA
6Hold$1.80N/ADowngrades
a year ago
Staar Surgical CoSTAA
2Hold$17.00N/AReiterates
a year ago
Establishment Labs Holdings IncESTA
2Strong Buy$52.00N/AReiterates
a year ago
Paragon 28 IncFNA
1Hold$13.00N/ADowngrades
a year ago
Myriad Genetics IncMYGN
4Hold$20.00N/AReiterates
a year ago
Castle Biosciences IncCSTL
7Strong Buy$41.00N/AReiterates
a year ago
Dermtech IncDMTKQ
4Hold$1.50N/AReiterates
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.